J&J, Glaxo are tops in social media, but smaller drugmakers rate highly, too
13/12/2014Using Twitter to study pharmaceutical drug side effects – iMedicalApps
13/12/2014Standard Social Media Practices Are Risky For Big Pharma – Law360
Despite the clear interest in social media engagement by two of its key stakeholders — patients and physicians — the pharma industry has been relatively slow on the uptake. Chief among the concerns is inadvertently violating U.S. Food and Drug Administration regulations that are in place to guard patient welfare, says Sharon Roberg-Perez of Robins Kaplan Miller & Ciresi LLP.
Source: www.law360.com
